PROTEUS SYNDROME
Clinical trials for PROTEUS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PROTEUS SYNDROME trials appear
Sign up with your email to follow new studies for PROTEUS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for rare overgrowth disorder: new drug trial launches
Disease control Recruiting nowThis study tests a daily pill called miransertib in people with Proteus syndrome, a rare condition causing abnormal tissue growth. The goal is to see if the drug can safely slow or stop this overgrowth. About 45 participants aged 3 and older will take the drug for up to 4 years, …
Matched conditions: PROTEUS SYNDROME
Phase: PHASE2 • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
Scientists seek clues to rare overgrowth disease in new study
Knowledge-focused Recruiting nowThis study aims to learn more about Proteus syndrome, a rare condition that causes abnormal growth of bones, skin, and other tissues. Researchers will examine up to 1,500 participants to understand the genetic causes and how the disease changes over time. The study involves medic…
Matched conditions: PROTEUS SYNDROME
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC